Diabetes, Obesity and Metabolism , 2025
[1] [2] When administered at therapeutic doses, tirzepatide enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite
Those errors can translate into either subtherapeutic dosing (no benefit, wasted cost) or supratherapeutic spikes (severe nausea, hypoglycemia in some patients, dehydration, or other adverse effects)
A study carried out by researchers at Cleveland Clinic (United States) has shown that the change in the bacteria living in the digestive tract leads to an increase in a compound related to the development of arteriosclerosis (narrowing or obstruction of the arteries)
Member of trial team that obtained a complete defense verdict for one of the worlds largest medical device manufacturers in a product liability lawsuit related to a surgical airway fire